Business News Martin Shkreli

  • Activists hold signs containing the image of Turing Pharmaceuticals CEO Martin Shkreli in front the building that houses Turing's offices, in New York, Thursday, Oct. 1, 2015, during a protest highlighting pharmaceutical drug pricing.

    The Turing Pharmaceuticals CEO says that the price increase of the drug Daraprim won't affect overall prescription cost trends.

  • Martin Shkreli

    Turing Pharmaceuticals will lower the price of its drug Daraprim amid backlash over a sudden spike, NBC News confirmed.

  • Martin Shkreli

    Martin Shkreli was accused by an ex-employee of contacting the man's family repeatedly during a lawsuit.